We conducted an economic impact analysis to study the repercussion of inappropriate antibiotic use. We specifically looked at upper respiratory tract infections (URIs) in Ghana. Our study indicates that inappropriate antibiotic use leads to substantial economic costs in a LMIC setting that could have been prevented. We recommend investment in novel strategies to counter these unnecessary expenditures. As the projections indicate, this may result in considerable cost reductions. By tackling inappropriate use, progress can be made in combatting antibiotic resistance.
The study can be accessed here.